235 related articles for article (PubMed ID: 16897672)
1. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
Shuford JA; Rouse MS; Piper KE; Steckelberg JM; Patel R
J Infect Dis; 2006 Sep; 194(5):710-3. PubMed ID: 16897672
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
3. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Ko KS; Lee JY; Song JH; Peck KR
J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
[TBL] [Abstract][Full Text] [Related]
5. Antifungal combinations against Candida albicans biofilms in vitro.
Bachmann SP; Ramage G; VandeWalle K; Patterson TF; Wickes BL; López-Ribot JL
Antimicrob Agents Chemother; 2003 Nov; 47(11):3657-9. PubMed ID: 14576141
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
[TBL] [Abstract][Full Text] [Related]
8. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
Ramage G; Jose A; Sherry L; Lappin DF; Jones B; Williams C
Antimicrob Agents Chemother; 2013 May; 57(5):2369-71. PubMed ID: 23422915
[TBL] [Abstract][Full Text] [Related]
10. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.
Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB
Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
Cateau E; Rodier MH; Imbert C
J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model.
Seidler M; Salvenmoser S; Müller FM
FEMS Yeast Res; 2010 Jun; 10(4):492-5. PubMed ID: 20345899
[TBL] [Abstract][Full Text] [Related]
14. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.
Ramage G; VandeWalle K; Bachmann SP; Wickes BL; López-Ribot JL
Antimicrob Agents Chemother; 2002 Nov; 46(11):3634-6. PubMed ID: 12384379
[TBL] [Abstract][Full Text] [Related]
17. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.
Uppuluri P; Srinivasan A; Ramasubramanian A; Lopez-Ribot JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3591-3. PubMed ID: 21518839
[TBL] [Abstract][Full Text] [Related]
18. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
Mukherjee PK; Long L; Kim HG; Ghannoum MA
Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
Lazzell AL; Chaturvedi AK; Pierce CG; Prasad D; Uppuluri P; Lopez-Ribot JL
J Antimicrob Chemother; 2009 Sep; 64(3):567-70. PubMed ID: 19584104
[TBL] [Abstract][Full Text] [Related]
20. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
